Part B Note: (a) Part B shall be completed when the applicant is proposing to establish an Incorporated Cell of an Incorporated Cell Company in terms of the Companies Act (SICAV Incorporated Cell Companies) Regulations. When completing Q.1.2, applicants shall bear in mind that the incorporated cell must have at least one director who is also a member of the board of directors of the incorporated cell company (‘ICC’). Where the scheme will be established as an IC of an ICC, the scheme shall be established as an open-ended SICAV ICC. Unless otherwise stated, any reference to subfunds within Part B shall be deemed to refer to incorporated cells of incorporated cell companies. Schemes which will be established as self-managed schemes shall provide the additional information required in Section 4 of this Application Form. Part B should be signed by the directors of the incorporated cell. Name of the incorporated cell of the directors of the incorporated cell Name of the incorporated cell company of the incorporated cell will be forming part: The scheme will be marketed as: EuVECA EuSEF The scheme will not be marketed using the EuVECA or EuSEF designations The incorporated cell will be issuing classes of shares constituting sub-funds: Yes No The incorporated cell will be: managed by an external manager self-managed The incorporated cell intends appointing the following service providers? Fund administrator Investment advisor Custodian The incorporated cell intends to seek a listing on a regulated market? Yes No The listing will be: a primary listing a secondary listing
investment scheme licence in favour of a scheme as an incorporated cell company/incorporated cell. identifying the person(s) responsible for signing the application documents; identifying the person(s) responsible for acting as a of liaison with the MFSA; identifying the person(s) responsible on behalf of the governing body of the scheme for its compliance obligations; identifying the person(s) responsible on behalf of the governing body of the scheme for its anti-money laundering obligations; approving and assuming responsibility for the contents of the offering document; Personal questionnaires of the: investment manager; compliance officer; money laundering reporting officer; and investment advisor (where applicable) Additional documents to be submitted when the scheme is established as an investment company in terms of: the Companies Act (Investment Companies with Variable Capital) Regulations; the Companies Act (SICAV Incorporated Cell Company) Regulations; the Companies Act (Recognised Incorporated Cell Company) Regulations. Personal questionnaires of the directors of the scheme: individuals: personal questionnaires of the proposed director(s); corporate and regulated in a recognised jurisdiction: details of the regulatory status of the proposed corporate director(s); name of the individual(s) that will represent the corporate director on the board of directors of the scheme. Personal questionnaires of the founder shareholders which hold more than 10% of the voting shares: individuals: personal questionnaires of the founder shareholder(s); if corporate and regulated in a recognised jurisdiction: details of the regulatory status of the proposed corporate founder shareholder(s); if corporate and not regulated in a recognised jurisdiction: personal questionnaire of the directors of the proposed corporate founder shareholder(s); personal questionnaire of the qualifying beneficial owners of the proposed corporate founder shareholder(s); and last years audited financial statements of the proposed corporate founder shareholder(s). Note: The MFSA reserves the right to request additional information in the case of corporate structures